A green strategy to produce potential substitute resource for bear bile using engineered Saccharomyces cerevisiae

Lina Jin , Li Yang , Shujuan Zhao , Zhengtao Wang

Bioresources and Bioprocessing ›› 2022, Vol. 9 ›› Issue (1) : 32

PDF
Bioresources and Bioprocessing ›› 2022, Vol. 9 ›› Issue (1) : 32 DOI: 10.1186/s40643-022-00517-3
Short Report

A green strategy to produce potential substitute resource for bear bile using engineered Saccharomyces cerevisiae

Author information +
History +
PDF

Abstract

Background

Bear bile powder is a precious natural material characterized by high content of tauroursodeoxycholic acid (TUDCA) at a ratio of 1.00–1.50 to taurochenodeoxycholic acid (TCDCA).

Results

In this study, we use the crude enzymes from engineered Saccharomyces cerevisiae to directionally convert TCDCA from chicken bile powder to TUDCA at the committed ratio in vitro. This S. cerevisiae strain was modified with heterologous 7α-hydroxysteroid dehydrogenase (7α-HSDH) and 7β-hydroxysteroid dehydrogenase (7β-HSDH) genes. S. cerevisiae host and HSDH gene combinatorial optimization and response surface methodology was applied to get the best engineered strain and the optimal biotransformation condition, respectively, under which 10.99 ± 0.16 g/L of powder products containing 36.73 ± 6.68% of TUDCA and 28.22 ± 6.05% of TCDCA were obtained using 12.00 g/L of chicken bile powder as substrate.

Conclusion

This study provides a healthy and environmentally friendly way to produce potential alternative resource for bear bile powder from cheap and readily available chicken bile powder, and also gives a reference for the green manufacturing of other rare and endangered animal-derived valuable resource.

Keywords

Tauroursodeoxycholic acid / Hydroxysteroid dehydrogenase / Biotransformation / Saccharomyces cerevisiae

Cite this article

Download citation ▾
Lina Jin, Li Yang, Shujuan Zhao, Zhengtao Wang. A green strategy to produce potential substitute resource for bear bile using engineered Saccharomyces cerevisiae. Bioresources and Bioprocessing, 2022, 9(1): 32 DOI:10.1186/s40643-022-00517-3

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Beach A, Richard VR, Bourque S, . Lithocholic bile acid accumulated in yeast mitochondria orchestrates a development of an anti-aging cellular pattern by causing age-related changes in cellular proteome. Cell Cycle, 2015, 14: 1643-1656.

[2]

Bruder S, Reifenrath M, Thomik T, . Parallelised online biomass monitoring in shake flasks enables efficient strain and carbon source dependent growth characterisation of Saccharomyces cerevisiae. Microb Cell Fact, 2016, 15: 1-14.

[3]

Eggert T, Bakonyi D, Hummel W. Enzymatic routes for the synthesis of ursodeoxycholic acid. J Biotechnol, 2014, 191: 11-21.

[4]

Fang X, Duan RS, Yang HY, Liu JF. Hyaluronic acid production by genetic modified GRAS strains. Adv Mater Res, 2014, 950: 13-17.

[5]

Feng Y, Siu K, Wang N, . Bear bile: dilemma of traditional medicinal use and animal protection. J Ethnobiol Ethnomed, 2009, 5: 2.

[6]

Ferrandi EE, Bertolesi GM, Polentini F, . In search of sustainable chemical processes: cloning, recombinant expression, and functional characterization of the 7α- and 7β-hydroxysteroid dehydrogenases from Clostridium absonum. Appl Microbiol Biotechnol, 2012, 95: 1221-1233.

[7]

Huang B, Zhao Q, Zhou JH, Xu G. Enhanced activity and substrate tolerance of 7α-hydroxysteroid dehydrogenase by directed evolution for 7-ketolithocholic acid production. Appl Microbiol Biotechnol, 2019

[8]

Lee J-Y, Arai H, Nakamura Y, . Contribution of the 7β-hydroxysteroid dehydrogenase from Ruminococcusgnavus N53 to ursodeoxycholic acid formation in the human colon. J Lipid Res, 2013, 54: 3062-3069.

[9]

Li L, Liu C, Mao W, . Taurochenodeoxycholic acid inhibited AP-1 activation via stimulating glucocorticoid receptor. Molecules, 2019, 24: 1-10.

[10]

Lian J, Mishra S, Zhao H. Recent advances in metabolic engineering of Saccharomyces cerevisiae: new tools and their applications. Metab Eng, 2018, 50: 85-108.

[11]

Liu L, Braun M, Gebhardt G, . One-step synthesis of 12-ketoursodeoxycholic acid from dehydrocholic acid using a multienzymatic system. Appl Microbiol Biotechnol, 2013, 97: 633-639.

[12]

Lu Q, Jiang Z, Wang Q, . The effect of tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation. Ann Hepatol, 2021, 23.

[13]

Momose T, Tsubaki T, Iida T, Nambara T. An improved synthesis of taurine- and glycine-conjugated bile acids. Lipids, 1997, 32: 775-778.

[14]

Rogowska-Wrzesinska A, Larsen PM, Blomberg A, . Comparison of the proteomes of three yeast wild type strains: CEN.PK2, FY1679 and W303. Comp Funct Genomics, 2001, 2: 207-225.

[15]

Rosa LRO, Vettorazzi JF, Zangerolamo L, . TUDCA receptors and their role on pancreatic beta cells. Prog Biophys Mol Biol, 2021

[16]

Shi J, Wang J, Yu L, . Rapidly directional biotransformation of tauroursodeoxycholic acid through engineered Escherichia coli. J Ind Microbiol Biotechnol, 2017, 44: 1073-1082.

[17]

Song C, Wang B, Tan J, . Discovery of tauroursodeoxycholic acid biotransformation enzymes from the gut microbiome of black bears using metagenomics. Sci Rep, 2017, 7: 1-8.

[18]

Toledo A, Yamaguchi J, Wang JY, . Taurodeoxycholate stimulates intestinal cell proliferation and protects against apoptotic cell death through activation of NF-κB. Dig Dis Sci, 2004, 49: 1664-1671.

[19]

Tonin F, Arends IWCE. Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review. Beilstein J Org Chem, 2018, 14: 470-483.

[20]

Wang J, Xiong A-Z, Cheng R-R, . Systematical analysis of multiple components in drainage bear bile powder from different sources. China J Chin Mater Med, 2018, 43: 2326-2332.

[21]

Xu Y, Yang L, Zhao S, Wang Z. Large-scale production of tauroursodeoxycholic acid products through fermentation optimization of engineered Escherichia coli cell factory. Microb Cell Fact, 2019, 18: 34.

[22]

Yang L, Xiong A, He Y, . Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry. Chem Res Toxicol, 2008, 21: 2280-2288.

[23]

Yoshimoto T, Higashi H, Kanatani A, . Cloning and sequencing of the 7 alpha-hydroxysteroid dehydrogenase gene from Escherichia coli HB101 and characterization of the expressed enzyme. J Bacteriol, 1991, 173: 2173-2179.

[24]

Zangerolamo L, Vettorazzi JF, Rosa LRO, . The bile acid TUDCA and neurodegenerative disorders: an overview. Life Sci, 2021, 272.

[25]

Zheng MM, Wang RF, Li CX, Xu JH. Two-step enzymatic synthesis of ursodeoxycholic acid with a new 7β-hydroxysteroid dehydrogenase from Ruminococcus torques. Process Biochem, 2015, 50: 598-604.

[26]

Zheng MM, Chen KC, Wang RF, . Engineering 7β-Hydroxysteroid dehydrogenase for enhanced ursodeoxycholic acid production by multiobjective directed evolution. J Agric Food Chem, 2017, 65: 1178-1185.

[27]

Zhou C, Shi Y, Li J, . The effects of taurochenodeoxycholic acid in preventing pulmonary fibrosis in mice. Pak J Pharm Sci, 2013, 26: 761-765.

Funding

National Major Science and Technology Projects of China(2017ZX09309006)

Natural Science Foundation of Shanghai(21ZR1463000)

AI Summary AI Mindmap
PDF

172

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/